GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (OTCPK:SGIOF) » Definitions » ROE % Adjusted to Book Value

SGIOF (Shionogi) ROE % Adjusted to Book Value : 11.36% (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Shionogi ROE % Adjusted to Book Value?

Shionogi's ROE % for the quarter that ended in Sep. 2024 was 16.24%. Shionogi's PB Ratio for the quarter that ended in Sep. 2024 was 1.43. Shionogi's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 11.36%.


Shionogi ROE % Adjusted to Book Value Historical Data

The historical data trend for Shionogi's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi ROE % Adjusted to Book Value Chart

Shionogi Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.55 6.55 5.30 10.26 7.68

Shionogi Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.12 7.73 6.58 - 11.36

Competitive Comparison of Shionogi's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Shionogi's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shionogi's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shionogi's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Shionogi's ROE % Adjusted to Book Value falls into.



Shionogi ROE % Adjusted to Book Value Calculation

Shionogi's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=13.13% / 1.71
=7.68%

Shionogi's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=16.24% / 1.43
=11.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shionogi ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Shionogi's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Shionogi Business Description

Traded in Other Exchanges
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi Headlines

From GuruFocus

Shionogi & Co Ltd R&D Meeting Transcript

By GuruFocus Research 02-14-2024